STOCK TITAN

Amylyx Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 9, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) will report its Q3 2023 financial results on November 9, 2023. The senior management team will host a conference call and webcast at 8:00 a.m. ET to discuss the results. The conference call details can be found on the company's website.
Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) will report its third quarter 2023 financial results on Thursday, November 9, 2023. Amylyx’ senior management team will host a conference call and audio webcast at 8:00 a.m. ET to discuss the financial results and other company updates.

To access the conference call, please dial (833) 816-1395 (U.S.) or +1 (412) 317-0488 (international) at least 10 minutes prior to the start time and ask to be joined into the Amylyx Pharmaceuticals call. A live audio webcast of the call will be available under “Events and Presentations” in the Investor section of the Company’s website, https://investors.amylyx.com/news-events/events. The webcast will be archived and available for replay for 90 days following the event.

About Amylyx Pharmaceuticals

Amylyx Pharmaceuticals, Inc. is committed to supporting and creating more moments for the neurodegenerative disease community through the discovery and development of innovative new treatments. Amylyx is headquartered in Cambridge, Massachusetts and has operations in Canada and EMEA. For more information, visit amylyx.com and follow us on LinkedIn and X, formerly known as Twitter. For investors, please visit investors.amylyx.com.

Media

Amylyx Media Team

+1 (857) 799-7274

amylyxmediateam@amylyx.com

Investors

Lindsey Allen

Amylyx Pharmaceuticals, Inc.

+1 (857) 320-6244

Investors@amylyx.com

Source: Amylyx Pharmaceuticals, Inc.

FAQ

When will Amylyx Pharmaceuticals report its Q3 2023 financial results?

Amylyx Pharmaceuticals will report its Q3 2023 financial results on November 9, 2023.

What is the stock symbol for Amylyx Pharmaceuticals?

The stock symbol for Amylyx Pharmaceuticals is AMLX.

How can I access the conference call and webcast?

To access the conference call, dial (833) 816-1395 (U.S.) or +1 (412) 317-0488 (international) at least 10 minutes prior to the start time and ask to be joined into the Amylyx Pharmaceuticals call. The webcast will be available on the company's website.

How long will the webcast be available for replay?

The webcast will be archived and available for replay for 90 days following the event.

Amylyx Pharmaceuticals, Inc.

NASDAQ:AMLX

AMLX Rankings

AMLX Latest News

AMLX Stock Data

350.97M
54.18M
14.32%
82.47%
1.88%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
CAMBRIDGE